14 results
diagnosis management vasculitis lupus acr2021 algorithm antibodies differential diseases druginduced erythematosus polyangiitis summary systemic table ana anterior antibody antineutrophil antinuclear
ANA (Antinuclear Antibody) and ANCA (Antineutrophil cytoplasmic antibodies) • Systemic lupus erythematosus 1. Anti-dsDNA
in drug-induced SLE ... + 90% • Granulomatosis ... + 90% • Granulomatosis ... • Eosinophilic granulomatosis ... antibodies #diagnosis #rheumatology
Granulomatosis with Polyangiitis (GPA) and Microscopic Polyangiitis (MPA) - ANCA Vasculitis Management Algorithm - ACR/VF 2021
Granulomatosis with ... Polyangiitis (MPA) - ANCA ... - ACR/VF 2021 Guidelines ... Vasculitis #Management #Treatment ... #algorithm #rheumatology
Eosinophilic Granulomatosis with Polyangiitis (EGPA) - ANCA Vasculitis Management Algorithm - ACR/VF 2021 Guidelines • Active
Eosinophilic Granulomatosis ... Polyangiitis (EGPA) - ANCA ... - ACR/VF 2021 Guidelines ... Vasculitis #Management #Treatment ... #algorithm #rheumatology
Autoantibodies and their Disease Associations ANA - Non-specific; common in SLE, autoimmune hepatitis Anti-CCP, Rheumatoid factor - RA Anti-dsDNA
- Drug-induced SLE ... Graves' disease c-ANCA ... Wegener's granulomatosis ... p-ANCA - Vasculitis ... diagnosis #table #rheumatology
Vasculitis Management - ACR/VF 2021 Guidelines for Treatment & Management • Giant Cell Arteritis (GCA) •
- ACR/VF 2021 Guidelines ... for Treatment & ... Nodosa (PAN) • Granulomatosis ... #ACR2021 #Guidelines ... #algorithm #rheumatology
Drug Induced Lupus vs SLE Drug Induced Lupus (DIL): • Epidemiology: -10% of all lupus cases, drug-dependent,
Induced Lupus vs SLE ... constitutional symptoms • Treatment ... life-threatening • Treatment ... #comparison #table ... #rheumatology #
Systemic Lupus Erythematosus (SLE) - Diagnosis and Management Summary • Epidemiology: 10-180/100,000, Typically Age 20-40, F:M
Erythematosus (SLE ... Workup: - ANA ... 50-60% - pANCA ... life-threatening • Treatment ... Management #Summary #rheumatology
Vasculitis and Vasculitides - Differential Diagnosis Framework When to Consider Vasculitis: • Purpura, ischemic skin lesions •
Associated - ANCA ... glomerulonephritis - Granulomatous ... VESSEL VASCULITIS (Granulomatous ... vasculitis, and SLE ... differential #diagnosis #rheumatology
Systemic Lupus Erythematosus - Summary Antinuclear (ANA) - 95% - Initial screening test Anti-dsDNA - 50% • Associated
Antinuclear (ANA ... • Specific for SLE ... severe disease Treatment ... Erythematosus #SLE ... Summary #diagnosis #rheumatology
Vasculitis - Differential Diagnosis Framework When to Consider Vasculitis: • Purpura, ischemic skin lesions • Mononeuritis multiplex • Hematuria, proteinuria,
diseases, such as SLE ... VESSEL VASCULITIS (GRANULOMATOUS ... /hr • Biopsy: Granulomatous ... (Eosinophilic Granulomatosis ... Differential #Diagnosis #Rheumatology
No results found for "CIDP treatment rheumatology comparison guidelines granulomatosis anca sle"
Try removing search terms or sorting by relevance
Or Upload an image for you and others searching for #CIDP #treatment #rheumatology #comparison #guidelines #granulomatosis #anca #sle